| MC 2674 N-Acetyl cysteine, [cysteine-2-14C]- | |
|
HPLC purified, Delivered ≥ 96% pure with dated HPLC radiochromatogram
|
|
| Solid under argon | |
| > 45 mCi(1.665 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W. 163.19  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MC 2398 N-Acetyl-D-cysteine, [1-14C]- | |
|
HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
|
| Solid | |
| > 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W. 163.19 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MC 2395 N-Acetyl-L-cysteine, [1-14C]- | |
|
HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
| Solid | |
| > 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W. 163.19 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |